Ignite Creation Date:
2024-05-05 @ 5:23 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00444015
Status:
COMPLETED
Last Update Posted:
2017-02-23
First Post:
2007-03-05
Brief Title:
Phase I DasatinibErlotinib in Recurrent Non-small Cell Lung Cancer NSCLC
Sponsor:
H Lee Moffitt Cancer Center and Research Institute
Organization:
H Lee Moffitt Cancer Center and Research Institute
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-03
Start Date Type:
None
Primary Completion Date:
2010-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-08
Completion Date Type:
ACTUAL
First Submit Date:
2007-03-05
First Submit QC Date:
March 6 2007
Study First Post Date:
2007-03-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-02-20
Last Update Post Date:
2017-02-23
Last Update Post Date Type:
ACTUAL